Increase in serum magnesium level in haemodialysis patients receiving sevelamer hydrochloride

International Urology and Nephrology

Volumn 37, Issue 2, 2005, Pages 321-328

  Mitsopoulos, Efstathios ^a   Griveas, Ioannis ^a   Zanos, Stavros ^a   Anagnostopoulos, Konstantinos ^a   Giannakou, Anastasia ^a   Pavlitou, Aikaterini ^a   Sakellariou, Georgios ^a  

^a PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

Author keywords

Haemodialysis; Lipids; Magnesium; Parathyroid hormone; Sevelamer hydrochloride

Indexed keywords

APOLIPOPROTEIN A1; CALCIUM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; PHOSPHORUS; SEVELAMER;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HEMODIALYSIS; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAGNESIUM BLOOD LEVEL; MALE; MULTIVARIATE ANALYSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

FEMALE; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; POLYAMINES; RENAL DIALYSIS;

EID: 25144471667     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-004-7135-5     Document Type: Article

References (26)

1. EA Slatopolsky SK Burke MA Dillon 1999 The Renagel Study Group Renagel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone Kidney Int 55 299-307 10.1046/ j.1523-1755.1999.00240.x 9893140
2. GM Chertow SK Burke MA Dillon E Slatopolsky 1999 For the Renagel Study Group. Long term effects of sevelamer hydrochloride on the calcium × phosphate product and lipid profile of haemodialysis patients Nephrol Dial Transplant 14 2907-2914 10.1093/ndt/14.12.2907 10570096
3. GM Chertow SK Burke P Raggi 2002 For the Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in haemodialysis patients Kidney Int 62 245-252 10.1046/ j.1523-1755.2002.00434.x 12081584
4. HS Rasmussen P Aurup K Goldstein et al. 1989 Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease: A double-blind, placebo controlled study Arch Intern Med 149 1050-1053 10.1001/archinte.149.5.1050 2719498
5. F Corica A Allegra A Di Benedetto et al. 1994 Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus Magnes Res 7 43-47 8054260
6. R Kirsten B Heintz K Nelson et al. 1988 Magnesium pyridoxal 5-phosphate glutamate reduces hyperlipidaemia in patients with chronic renal insufficiency Eur J Clin Pharmacol 34 133-137 10.1007/BF00614549 3383985
7. BK Gupta D Glicklich VA. Tellis 1999 Magnesium repletion therapy improves lipid metabolism in hypomagnesemic renal transplant recipients Transplantation 67 1485-1487 10.1097/00007890-199906150-00017 10385091
8. IN Cholst SF Steinberg PJ Tropper et al. 1984 The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects N Engl J Med 310 1221-1225 6709029
9. H Meema D Oreopoulos A. Rapoport 1987 Serum magnesium level and arterial calcification in end-stage renal disease Kidney Int 32 388-394 3669498
10. BS Levine JW. Coburn 2001 Magnesium metabolism In: SG Massry RJ Glassock eds. Massry and Glassock's Textbook of Nephrology. (4th edn.) Lippincott Williams and Wilkins Philadelphia PA 341-344 chapter 18.
11. MB Andon JZ Ilich MA Tzagournis V. Matkovic 1996 Magnesium balance in adolescent females consuming a low- or high-calcium diet Am J Clin Nutr 63 950-953 8644692
12. DI Goldberg MA Dillon EA Slatopolsky et al. 1998 Effect of Renagel, a non-absorbed, calcium- and aluminium-free phosphate binder, on serum phosphorus, calcium, and intact parathyroid hormone in end stage renal disease patients Nephrol Dial Transplant 13 2303-2310 10.1093/ndt/ 13.9.2303 9761513
13. GA. Quamme 1997 Renal magnesium handling: New insights in understanding old problems Kidney Int 52 1180-1195 9350641
14. D Blumberg A Bonetti V Jacomella et al. 1998 Free circulating magnesium and renal magnesium handling during acute metabolic acidosis in humans Am J Nephrol 18 233-236 10.1159/000013342 9627040
15. CC Marone RA. Sutton 1983 Effects of acute metabolic acid - base changes and furosemide on magnesium excretion in rats Metabolism 32 1033-1037 10.1016/0026-0495(83)90073-2 6621362
16. NL Wong GA Quamme JH. Dirks 1986 Effects of acid - base disturbances on renal handling of magnesium in the dog Clin Sci 70 277-284 3948477
17. RJ Shapiro CK Yong GA. Quamme 1987 Influence of chronic dietary acid on renal tubular handling of magnesium Pflugers Arch 409 492-498 10.1007/ BF00583806 3627965
18. EJ Brink AC. Beynen 1992 Nutrition and magnesium absorption: A review Prog Food Nutr Sci 16 125-162 1496118
19. JF Navarro C Mora A Jimenez et al. 1999 Relationship between serum magnesium and parathyroid hormone levels in haemodialysis patients Am J Kidney Dis 34 43-48 10401014
20. MS Djurhuus NAH Klitgaard KK Pedersen et al. 2001 Magnesium reduces insulin-stimulated glucose uptake and serum lipid concentrations in type 1 diabetes Metabolism 50 1409-1417 10.1053/meta.2001.28072 11735085
21. Y Rayssiguier L Noe J Etienne et al. 1991 Effect of magnesium deficiency on post-heparin lipase activity and tissue lipoprotein lipase in the rat Lipids 26 182-186 2046484
22. P Jaya PA. Kurup 1987 Magnesium deficiency and metabolism of lipids in rats fed cholesterol-free and cholesterol-containing diet Indian J Biochem Biophys 24 92-95 3666782
23. S Humphries H Kushner B. Falkner 1999 Low dietary magnesium is associated with insulin resistance in a sample of young, nondiabetic Black Americans Am J Hypertens 12 747-756 10.1016/S0895-7061(99)00041-2 10480466
24. PO Attman O Samuelsson P. Alaupovic 1993 Lipoprotein metabolism and renal failure Am J Kidney Dis 21 573-592 8503411
25. RM. Mclean 1994 Magnesium and its therapeutic uses: A review Am J Med 96 63-76 10.1016/0002-9343(94)90117-1 8304365
26. AL Boskey AS. Poshner 1980 Effect of magnesium on lipid-induced calcification: An in vitro model of bone mineralization Calcif Tissue Int 32 139-143 6773631